Consumer Law Library

Stanley Laboratories, Inc

Volume 34 · 34 F.T.C. 972

Citation
34 F.T.C. 972
Docket
4130
Complaint
1940-05-01
Decision
1942-04-01
Document type
final order
Case type
consumer protection
Industry
feminine hygiene products
Relief
cease_and_desist; compliance_reporting
Commission counsel
llfr. R. P. Bellinger and .1/r. Carrel F. Rhodes
Respondent counsel
of Portland, Oreg
Source
Original volume PDF
Original PDF
This decision as a PDF

deceptive advertisinghealth claims

Cite this decision

Stanley Laboratories, Inc, 34 F.T.C. 972 (1942). Consumer Law Library, https://consumerlawlibrary.org/decisions/v034-0087

Report an error in this record (decision id v034-0087)

Order status: unknown. Sunset may be extended by the latest qualifying federal-court complaint alleging an order violation; complaints, dismissal/appeal outcomes, and respondent-specific extensions are not fully tracked.

Cited by 0 later FTC decisions

Cites

Text (OCR of the scan at left; may contain errors)

IN THE MATTER OF STANLEY LABORATORIES, INC., ED\VARD A. BACHMAN TRADING AS STILLMAN PRODUCTS COMPANY AND AS STANLEY LABORATORIES COMPLAINT, FINDINGS, AND ORDER IN HEG.\RD TO 'fhe ALLEGED VIOLATION OF SEC. ~ OF AN ACT OF CO~GUESS APPROVED SEPT. 26, 1914 Docket 4130. Comp/a.int, May 1, 1940-Decision, April 1, 1942 WhHe a corporation and its presicl~nt, wlw controlled nnd uirectecl its bu,iner>~ activities, engaged in interstate sale and distribution of drug produds for feminine hygiene; in advertisements of their "M. D. Medicated Douche Powder" through the mails, in newspapers, clrculars, leaflets, folders, pnmphlets, and other advertising literature; directly and by implication- ( a) Represented that said powder was a recent development of scientific research which was endorsed by leading physicians ami surgeons; that lt was an antiseptic and germicide which would combat any form of bacteria; and that it bad competent remedial qualities for use on cuts, sores, and burns, and would relieve fatigue and annoying discharge sometimes connected therewith; and (b) Represented that said preparation constituted a contraceptive and a prophylactic against disease through use of such descriptive words and phrases as "dependable," "insure--personal hygiene," "dependable safeguard," "rellable safeguard," and "effective, reliable anti~eptic powder" in referring thereto;

'Vhen in fact said preparation was neither such a recent development, nor thus Pndursed; while the ingredient oxyquiuolin sulphate, commonly u~t>d in tmeh powders, has a spermatocidal action in direct concentration, under conditions ot use the proportion thereof was so small as to have little or no value; the ingredient phenol under conditions of use would have no germicidal pt·operties, but solely an antiseptic effect; use of the two together ln sufficient concentration to net as a germicide would have a tendency to Irritate and damage the tissues; and while laboratory tests indicated that the product contained a lmcteriostatlc, or germ-inhibiting, substance and had antiseptic properties, under the dissimilar conditions of use the value thereof was limited to that of a mild antis!'ptic; product had little or no therapeutic value in treatment of cuts, sores, and burns; use as a douche had no value In relieving fatigue, and would not affect the cause of any discharge; it dld not constitute a preventative against conception in excess of the mechanical pfi'ect of flushing the vagina, and was not a prophylactic against diseasp; and Where said corporation and individual- (c) Represented, through use of the term "Lahot·atories" in thrir corporate and trade names, and in their advertising material, that they owned, operated, and controlled a laboratory equipped for compounding medicinal prt>parations and for research In connection therewith; The facts being they were merely distrlbutot·s of product>~ eomponndt>d and manufactured by other concerns; and STANLEY LABORATORIES, 1:\C., ET AL. 973 !)72 Complaint (d) Fulst>ly represented that tllelr products wpre either prescribed or compounded by physicians or bore the endorsement or recommendation of the medical profession by use of the letters "l\I, D." in designating their product "M. D. Medicated Douche Powder" and by including in advertising thereof the like· ness of nurses llnd doctors, with a rPd ct'0>1S; tendency and capacity ot which was to muse the pmchnsing public to belie,·e that such pr·oducts were f>ndorsed and recommended by the mediral profession or hy the American Reu Cross.

With effect of misleading and deceiving a substantial portion of the purchasing public into the mistaken belief that such statements were true, thereby causing it, because of such mistaken belief, to purchase said products: HPld, That sufl acts and practices, under the cir<·umstances set forth, were all to the prejudice and injury of t~e public, and constituted unfair and deceptive acts and practices in commerce.

Before Mr. Williarn 0. Reeve., ami 1.llr. Oha:rules A. Vilas, trial examiners.

llfr. R. P. Bellinger and .1/r. Carrel F. Rhodes for the Commission. Mr. James J. Hayden, of Washington, D. C., and illr. Leo Levimon, of Portland, Oreg., for respondents.

Complaint • Pun;uant to the p1·ovisions of the Federal Trade Commission Act, and by virtue of the authority vested in it by said act, the Federal Trade Commission having reason to believe that Stanley Laboratories, Inc., a corporation, and Edward l •. Bachman, an individual trading us Stillman Products Co. and as Stanley Lnboratories, hereinafter referred to ns respondents, have violated the provisions of the said act, and it appearing to the Commission that a proceeding by it in respect thereof would be in the public interest, hereby issues its complaint, stating its charges in ttutt respect as follows: PARAGRAPH 1. Respo~dent, Stanley Laboratories, Inc., is n corporal ion organized, existing, und doing business under and by virtue of the laws of the State of Oregon, with its principal place of business located in Portland, Oreg. Respondent, Edward A. Bachman, is an individual, tmding as Stillman Products Co. and us Stanley Laboratories, who also has his office and principal place of business in Portland, Oreg., in connection with and located at the same address as the ('corporate respondent above named. The respondent Edward A. Bachman is also president of the corporate respondent Stanley Labomtories, Inc., and controls and directs the business activities, sales }>policies und practices of the corporate respondent. P.~o.n. 2. Re:spondents at·e now, and for more than 1 year last past have been, Pngaged in the business of selling and distributing certain drug products for feminine hygiene.

Complaint 341!'. T. C. Respondents designate their said products so sold and distributed as ":rtf. D. Medicated Douche Powder," "Contra-Jel," "Femeze," and "M. D. Supercones."

Respondents cause said products, when sold, to be transported from · their place of business in Oregon to the purchasers thereof located in various other States of the United States and in the District of Columbia.

Respondents maintain, and at all times mentioned herein have maintained, a course of trade in said products· in commerce between and among the various States of the United States and in the District of Columbia.

PAR. 3. In the course and conduct of their aforesaid business, the respondents have disseminated and are now disseminating, and have caused and are now causing the dissemination of false advertisements concerning their said products, by the United States mails and by various other means in commerce, as commerce is defined in the Fed- ~ral Trade Commission Act, for the purpose of inducing, and which are likely to induce, directly or indirectly, the purchase of said produ;ts; and respondents have also disseminated and are now disseminating, and have caused and are now causing the dissemination of false advertisements concerning their said products, by various means, for the purpose of inducing, and which are likely to induce, directly or indirectly, the purchase of their said products in commerce, as commerce is defined in the Federal Trade Commission Act. Among and typical of the false, misleading, and deceptive statements and representations contained in said false advertisements disseminated and caused to be disseminated as hereinabove set forth by the United States mails, by advertisements in newspapers, and by circulars, leaflets, folders, pamphlets, and other advertising literature, 1\re the following:

1. As to M. D. Medicated Douche Powder:

A VALUABLE PRESCRIPTION FOB DISCRIMINATING 'Women * * * produced for discrlmlnatlng modern women who desire a sanitary, and dependable douc·he to insure their personal hygiene. It Is but recently that scientific research has developed new and Improved methods to safeguard the health nud happiness of married women. Endorsed by physicians and surgeons. ll. D. l\Iedicateu Douche Powder not only cleans the vagina, and soothes the delicate membrane tissue, but lt has the added advantage of the protective action or oxyqulnolin sulphate, a dependable sarPguard. Because or Its many other beneficial uses, "M. D." 1s also a very valuable household remedy • • • for cuts, sores and burns.

l't{. D. Medicated Douche Powder, endorsed by leading physicians and sur· geons, Is a germicide-soothing and cooling to delicate membranes with the addition of oxyqulnolin sulphate-a reliable safeguard. STANLEY LABORATORIES, INC., ET AL. 975 tl72 Complaint Medical science now answers the problems of millions of women with a truly effective, reliable antiseptic powder.

Ed'active in combatting any form of bncteria. It relieves women of fatigue and the annoying discharge, often occasioned b' all day standing.

Manufactured by Stanley Laboratories.

2. As to Contra-Jel :

Contra-Jel Is the highest quality vnginlll antiseptic In jelly form. Its con sistem~y insures even distribution and prolonged contact with every part of the vaginal tract, and its protective action endures as long as it remains within the vagina • • * Contra-Jet is a harmless, non-Irritating, vaginal antiseptic and prophylactic • "' "' It is more convenient, sanitary and effective than are douches, tablets, capsules, or suppositories.

3. .As to :M. D. Supercones:

They are stable and do not lose their antisPptlc strength • • • a powerful yet non-irritating antiseptic • • * l\.1. D. Supercones remain in ell'active anthleptic contact for many hours • • • They are actually soothing and beneficial as well as antiseptic.

4. .As to Femeze:

Femeze has been found to be a simple effective prescription affording relief for the functional pains and cramps which accompany menstruation • • • bringing relief in a short time by relaxing the contl·acted womb muscles, allowing them to react in a natural way. It does not merely deaden your nerves With drugs or narcotics to stop the pain. Femeze contains no narcotics. PAn. 4. Through the use of the aforesaid statements and representations and others of similar import and meaning not specifically set out hei'ein, the respondents represent directly and by implication: 1. That M. D. Medicated Douche Powder is a recent development of scientific research which is endorsed by leading physicians and surgeons; that said preparation is a competent and effective contraceptive; that said preparation is an antiseptic and germicide which will combat any form of bacteria; that such preparation has competent remedial qualities for use on cuts, sores, and burns, and that said preparation will relieve fatigue and annoying discharge connected with the menstrual period.

2. That Contra-Jel gives immunity from pregnancy, protection from venereal disease, and has germicidal and antiseptic properties. 3. That M.D. Supercones constitute an effective contraceptive which has powerful antiseptic properties.

4. That Femeze is an effective treatment for functional pains and cramps which accompany menstruation and that said preparation will relax the womb muscles, allowing them to react in a natural way. 976 FEDERAL TRADE COMMISSION DECISIONS· Complaint 34 F. T. C. PAR. 5. In truth and in fact none of said products distributed by the respondents constitute competent or effective contraceptives and will not give immunity from pregnancy. None of said products constitute an adequate prophylactic and will not gi\'e protection from venera! diseases.

The product M. D. Medicated Douche Po,wcler is not a recent development of scientific research and is not endorsed by leading physicians or surgeons. Under the conditions of use recommended by the respondents this product is not a germicide and is not a reliable antiseptic effective in combatting any form of bacteria. This preparation would have very iittle therapeutic value in the treatment of cuts, sores, and burns generally. Such preparation has no therapeutic value in relieving fatigue or discharge c01mected with the menstrual period.

Respondents' preparation Femeze is not an effective treatment for functional pains and cramps in excess of possible lessening of sensitivity to pain which might accompany menstruation. There is no scientific basis for the representation that this preparation will relieve menstrual pain by relaxing the womb muscles and allowing them to react in a natural way, and respondents' said preparation will not accomplish such results.

Respondents'. repreparations, Contra-Jel and :M:. D. Supercones do not have germicidal properties nor do they constitute powerful antiseptics as the antiseptic properties of these preparations are comparatively mild.

PAR. 6. In addition to the statements and representations herein. above set forth, the respondents make false, deceptive, and misleading representations to the effect that their products are either prescribed or compounded by physicians or that they bear the endorsement or recommendation of the medical profession by means of the use of the letters "l\f. D." in designating their products l\L D. l\Iedicated Douche Powder and l\I. D. Supercones and by including therewith in advertising the likeness of nurses and doctors with the figure of a cross in simulation of the Red Cross emblem.

In truth and in fact said products are not prescribed or compounded by a physician or physicians and they have not received the endorsement or recommendation of the medical profession. PAR. 7. In addition to the above representations, the respondents, by the use of the tenn "laboratories'' in their corporate and trade names, and in their advertising literature, also represent that they own, operate, and control a laboratory equipped for the compounding of nwdicinal preparations and for research in connection therewith. In STA..."\TLEY LABORATORIES, I~C., ET AL. 977 972 Fin\liugs truth and in fact the respondents neither own nor control any factory,. plant, or laboratory wherein their medicinal preparations are compounded or wherein any research activities are conducted, but instead the respondents are merely distributors of products compounded and manufactured by other concerns.

PAH. 8. The use by the respondents of the foregoing false, deceptive, and misleading statements, representations, and advertisements disseminated as aforesaid has had, and now has, the capacity and tendency to, and does, mislead and deceive a substantial portion of the purchasing public into the erroneous and mistaken belief that such false statements, representations, rmd advertisements are true, and causes a portion of the purchasing public, because of such erroneous and mistaken beliefs, to purchase respondents' said preparations. PAR. V. Tile aforesaid acts and practices of the respondents, as herein alleged, are all to the prejudice and injury of the public and constitute unfair and deceptive acts and practices in commerce within the intel'\t and meaning of the Felleral Trade Commission Act. REPORT, FINDINGS AS TO THE FACTS, A;ND ORDER Pursuant to the provisions of the Federal Trade Commission Act,. the Federal Trade Commission, on :May 7 A. D. 1940, issued and subsequently served its complaint in this proceeding upon the respondents, Stanley Laboratories, Inc., a corporation, and Edward A. Bachman, an individual trading as Stillman Products Company and as Stanley Laboratories,_ charging them with the use of unfair and decep-· tive acts and practices in commerce in violation of the provisions of said act.

After the issuance of said complaint and the filing of respondents' answer thereto, testimony and other evidence in support of said complaint were introduced ~y R. P. Bellinger and Carrel F. Rhodes, attorneys for the Commission, and in opposition to the allegations of the complaint by James J. Hayden and Leo Levinson, attorneys for the respondents, before 'Villiam C. Reeves, a trial examiner of the Commission theretofore duly designated by it, and said testimony and other evidence were duly recorded and filed in the office of the Commission. Thereafter, this proceeding regularly came on for final hearing before the Commission upon said complaint, answer thereto, testimony and other evidence, re1)ort of the trial examiner upon the evidence and exceptions filed therrto, briefs in support of the complaint and in opposition thereto, and oral arguments of counsel; nnd the Commission having duly considered the mattrr and being now fully advised in the premises, finds that this proceeding is in the interest of the 46Guo6m--42--vol. 34----62 978 FEDERAL TRADE COll.:IMISSION DECISIONS Findings 34F. T. C.

public, and makes this its findings as to the facts and its conclusion drawn therefrom: · FINDINGS AS TO THE FACTS PARAGRAPH 1. Respondent, Stanley Laboratories, Inc., is a corporation organized, existing, and doing business under and by virtue of the laws of the State of Oregon, with its principal place of business located in Portland, Oreg.

Respondent, Edward A. Bachman, is an individual trading as Stanley Laboratories, who also has his office and principal place of business in Portland, Oreg., in connection with, and located at the same address as, the corporate responuent. Tile respondent Edward A. Bachman is also president of the corporate respondent Stanley Laboratories, Inc., and controls and directs the business activities, sales policies and practices of the corporate responuent. PAR. 2. Respondents are now, and for more than 1 year last past have been, engaged in the business of selling and distributing certain drug products for feminine hygiene, including a product designated "l\L D. Medicated Douche Powder." Respondents cause said products, when sold, to be transported from their place of business in the State of Oregon to purchasers thereof located in various other States of the United States and in the District of Columbia. Respondents main: tain, and at all times mentioned herein have maintained, a course of trade in said products in commerce between and among the various States of the United States and in the District of Columbia. PAR. 3. In the course and conduct of their business, the respondents have disseminated and are now disseminating, and httve caused and are now causing the dissemination, of false advertisements concerning their said products, by United States mails and by various other means in commerce as "commerce" is defined in the Federal Trade Commission Act; and respondents have also disseminated and are now disseminating, and have caused and are now causing the dissemination of, false advertisements concerning their said products, by various means, for the purpose of inducing, and which are likely to induce, <.lirectly or indirectly, the purchase of their said pro<.lucts in commerce as "commerce" is defined in the Fe<.leral Trade Commission Act. Among and typical of the false, misleading, and deceptive statements an<.l reprei'entations contained in said false advertisements <lisseminated and cause<.l to be disseminated as hereinabove set forth, by United States mails, by advertisements in newspapers, and by circulars, ]enflets, folders, pamphlets, and other advertising literature, are the following:

A VALUABLE PRESCBIPTIO!'i FOB DIS('R!MINATI:-;"0 \\OMFN • • • produced for discriminating modern women who desire a sanitary and llPpendable douche to STANLEY LABORATORIES, DW., ET AL. 979 {)72 Findings lnsure their personal hygiene. It is but recently that S('ientific research has developed new and lmpt·oved method~ to safeguard the health and happiness of married women. Endorsed by physicians anrl surg!'ons. M. D . .l\Iedicat!'d Douche Powd!'r not only deans the vagina, and soothes the delicate nwmbrane tissu£>, but it has the added advantage of the protective action of oxyqninolln sulphate, a dependable safeguard. Because of its many other beneficial uses, "l\1. D." is also a very valuable bousebold remedy • • • for cnts, :sores .and burns. l\1. D. Medicated Douche Powder, endorsed by lending physicians and surgeons, is a germicide--soothing and cooling to delicate membranes with the a<ltlition of oxyquiuolin sulphate--a reliable safeguard. Medical sciertce now answers the problems of millions of women with a truly effective, reliable antiseptic powder. Eff!'ctive in combatting any form of bacteria. It relieves women of fatigue and the annoying discharge, often occasioned by all day standing. • 1\Ianufartured by Stanley Laboratori!'s.

PAR. 4. Through the use of the aforesaid statem{:nts and representations, and others of similar import and meaning not specifically set out herein, the respondents represent, directly and by implication, that "M. D. Medicated Douche Powder" is a recent development of scientific research wl~ich is endorsed by leading physician~ and surgeons; that said preparation is an antiseptic and germicide which will combat any form of bacteria; that such preparation has competent remedial qualities for use on cuts, sores, and burns; and that said preparation wil relieve fatigue and annoying tlischar~e sometimes connected therewith.

The use by the respondents of such descriptive words and phrases as "dependable," "insure personal hygiene," "dependable safeguard," "reliable safeguard," and "effective, reliable antiseptic powder" in referring to, designating and describing said "1\f. D. Medicated Douche Powder," has a tendency and capacity to c;mse purchasers and prospective purchasers to believe that said preparation is a preventative against conception and a prophylactic against disease. PAR. 5. Respondents' preparation "1\I. D. Medicated Douche Powder" is composed of the following ingredients: Alum, zinc sulphate, boric acid powder, oxyquinolin sulphate, oil of white thyme, oil of peppermint, phenol, and eucalyptol. This preparation is not a recent development of scientific research and is not endorsed by leading physicians or surgeons. The ingredient oxyquinolin ~ulphate is commonly used in douche powders and has a spermatocidal action in direct concentration. Under conditions of use, however, the proportion of oxyquinolin sulphate is so small as to have little or no therapeutic value. The ingredient phenol appearing in respondents preparation is a germicide when used in sufficient concentl'atlon, but under the conditions of use in this preparation, this in~retlient would have 980 FEDERAL TRADE COMMISSION DECISIOKS Findings 34F.T. C.

no germicidal properties and its effect would be solely that of an antiseptic. The use o:f oxyquinolin sulphate and plwnol in sufficient concentration to act as a germicide, would have a tendency to irritate and damage the mucous membrane and other tis~ue with which it might come in contact.

A bacteriologist who testified on behalf of the respondents made a test of respondents' preparation "l\1. D. l\Iedicated Douche Powder" and :found that dilutions of one teaspoonful to a pint, and one teaspoonful to.a quart, had the ability to restrain the growth o:f test organism, indicating that the preparation had a bacteriostatic or germ-inhibiting substance in it and indicating antiseptic properties. Under the conditions of use, the germ-inhibiting ingredients of respondents' preparation do not rem!tin in direct or concentrated contact similar to that of a laboratory test and, consequently, the therapeutic value of this preparation is limited to that of a mild antiseptic. This preparation has little or no therapeutic Yalue in the treatment of cuts, sores, antl burns. The use of this preparation in the form o:f a douche might temporarily clean out the nginal tract but has no value in relieving fatigue and will not affect the cause of any discharge. Under conditions of use this preparation does not have either spermatocidal or germicidal prompt.>rties and will not constitute a preventath·e against conception in excess of the mechanical effect of flushing the vagina, and is not a prophylactic against disease.

P.1R. 6. In addition to the above representations, the respondents, by the use of the term "laboratories" in their corporate and trade names, and in their advertising literature, also represent that they own, operate, and control a laboratory equipped for the compounding of medicinal preparations and for research in connection therewith. In tmth and in fact, the respondents neither own nor control any factory, plant, or laboratory wherein their medicinal preparations arc compounded or wherein any research activities are conducted, but, instead, respondents are merely distributors of products compounded and manufactured by other concerns.

PAR. 7. In addition to the statements and representations hereinabove set forth, the respondents make false, deception, and misleading representations to the effect that theit· products are either prescribed or compounded by physicians or that they bear the endorsement or recommendation of the medical profession by means of the use of the letters "l\f. D." in designating their pr·oduct "M. D. Medicated Douche Powder" and by includin:? therewith, in nd,·ertising, the likeness of nurses and doctors, with the figure of a cross in simulation of the .American Red Cross emblem. In truth and in fact, said products are not prescribed or compounded by a physician or physicians and they STANLEY LABORATORIES, I~C., ET AL. 981 ~72 Ot·der have not receiveU. the endorsement or recommendation of the medical profession, and the use of the letters "M. D.", either alone or in combination with the likeness of nurses and doctors and the figure of a cross has a tendency and capacity to cause members of the purchasing public to believe that products so designatl:•d and described are endorsed and recommended by the medical profession. The use of a cross simulating the' American Ued Cross emblem in design, either alone or in combination with the letters "M. D." or with the picture of a nurse or doctor, has a tendency and capacity ·to cause members of the purchasing public to believe that the product is in some way endorsed or approved by the American Red Cross. PAR. 8. The Commission further finds that there is not sufficient evi- <lenee in the record as to the dissemination of any particular a<lvert.isement with reference· to respondents' preparations "Contra-Jel,n "Supercones," and "Ferneze'' to warrant any finding involving these 1n·oducts.

PAR. 9. The use by the respomlents of the foregoing false, deceptive, and misleading statements, representations, and advertisements disseminated as aforesaid, has had, and now has, the capacity and tendency to, and does, mislead and. deceive a substantial portion of the purchasing public into the erroneous and. mistaken belief that such false statements, representations and advertisements are true, and cause~ a portion of the purchasing public, because of such erroneous and mistaken belief, to purchase respondents' preparations. CONCLUSION The aforesaid acts and practices of the respondents, as herein found, are all to the prejudice and injury of the public, and constitute unfair and deceptive acts and practices in commerce within the intent and meaning of the Federal Trade Commission Act. OllDER TO CEASE AND DESIST This proceeding having been heard by the Feueral Trade Commission upon the complaint of the Commission, the answer of the re" 1-'pondents, testimony and other evidence taken before 'Villiam C. Reeves, a trial examiner of the Commission theretofore <luly designated by it, in support of the nllegations of the complaint and in opposition then•to, report of the trial examitwr upon the evidence and exceptions filed thereto, briefs in support of the complaint and in opposition thereto, and oral arguments of counsel; and the Commission having made its findings ag to the facts anJ its conclusion Order 3-!F. T. C. that said respondents have violated the provisions of the Federal Trade Commission Act.

It is ordered, That the respondents, Stanley Laboratories, Inc., a corporation, and its officers, and Edward A. Bachman, an individual trading as Stanley Laboratories, and their respective re.presentatives1 agents, and employees, directly or through any corporate or other device; in connection with the offering for sale, sale or distribution of their preparation "M. D. Medicated Douche Powde!'," or any other prepar.ation of substantially similar composition or possessing substantially similar properties, whether sold under the same name or under any other name, do forthwith cease and desist :from: 1. Disseminating, or causing to be disseminated, any advertisement, by means of the· United States mails, or by any means in commerce as "commerce" is defined in the Federal Trade Commission Act, which advertisement represents, directly or through inference. (a) That respondents' preparation is a recent development of scientific research, or that it is endorsed by physicians and surgeons. (b) That respondents' preparation has either germicidal or spermatocidal properties under conditions of use. (c) That respondents' preparation will combat any form of bacteria, or that it will have any effect upon any bucteria in excess of that of ll mild antiseptic.

(d) That respondents' preparation has any substantial therapeutic value in the treatment of cuts, sores, or burns. (e) That the use of respondents.' preparation will relieve fatigue or have any effect upon the cause of vaginal discharge. {f) That the use of respondents' preparation constitutes a preventative against conception, in excess of the mechanic.al effect of flushing the vagina.

(g) That respondents' preparation constitutes a prophylactic against disease.

2. Disseminating or causing to be disseminated any advertisement by means of the United States mails, or by any means in commerce as "commerce" is defined in the :Federal Trade Commission Act, which advertisement in designating or describing respondents' preparation ".M. D. :Medicated Douche Powder" or any othl:'r preparation of substantially similar composition or possessing substantially similar propertiP'>. or the effectiveness of the use of such preparation, uses the words "dependable," "dependable safeguard," "reliable safpguard,n "effective reliable antiseptic powder," or any other words of similar import or meaning, in such a manner as to infer or imply that such preparation is a contraceptive or prophylactic. STANLEY LABORATORIES, IN'C., ET AL. 983 972 Order 3. Disseminating, or causing to be disseminated, any adverti~ement by any means, for the purpose of inducing, or which is likely to induce, directly or indirectly, the purchase in commerce as "commerce" is defined in the Federal Trade Commission Act, of respondents' preparation, which advertisement contains any of the representations prohibited in paragraphs (1) and (2) hereof and the respective subdivisions thereof.

4. The use of th~ letters "M. D." in respondents' trade name, or in any other manner, either alone or in conjunction with the picturization of a doctor, nurse, or cross, to designate or describe respondents' preparation or any other preparation which has not been endorsed or recommendeu by the medical profession.

5. The use of the picturization of a cross or any other simulation of the American Red Cross emblem, either alone or in conjunction with the picturization of a doctor or a nurse, to designate or describe respondents' preparation.

6. Use of the word "Laboratories" or any other word of similar import or m·meaning in respondents' corporate or trade name, or representing through any other means or device, or in any manner, that the respondents own, operate, or control a laboratory equipped for the compounding of medicinal preparations and for research in connection therewith.

It w further order·ed, That the respondents shall, within 60 days after service upon them of this order, file with the Commission a report in writing, setting forth in detail the manner and form in which they have complied with this order.

Complaint 34 F. T. C.

← 34 F.T.C. 958 · 34 F.T.C. 984 →